Unknown

Dataset Information

0

Labeling Pediatric Products: BPCA Efforts and Orphan Drug Opportunities

ABSTRACT:

SUBMITTER: Wei H 

PROVIDER: S-EPMC12288554 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Pediatric Drug-Drug Interaction Studies: Barriers and Opportunities.
| S-EPMC6465091 | biostudies-literature
Unknown Natural products in drug discovery: advances and opportunities.
| S-EPMC7841765 | biostudies-literature
Unknown FDA Approval of Orphan Drug Indications for Pediatric Patients, 2011-2023.
| S-EPMC11791693 | biostudies-literature
Unknown Opportunities and Challenges in Drug Development for Pediatric Cancers.
| S-EPMC7933059 | biostudies-literature
Unknown Predictive Analysis for First Submission of Generic Drug Application for Orphan Drug Products Using Random Survival Forest.
| S-EPMC12497357 | biostudies-literature
Unknown Assessment of Dosing Strategies for Pediatric Drug Products.
| S-EPMC11338733 | biostudies-literature
Unknown The epigenome in pediatric acute lymphoblastic leukemia: drug resistance and therapeutic opportunities.
| S-EPMC8992636 | biostudies-literature
Unknown Leveraging Omeprazole PBPK/PD Modeling to Inform Drug-Drug Interactions and Specific Recommendations for Pediatric Labeling.
| S-EPMC11944414 | biostudies-literature
Unknown Challenges and Opportunities to Develop Enediyne Natural Products as Payloads for Antibody-Drug Conjugates.
| S-EPMC7850032 | biostudies-literature
Unknown Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy.
| S-EPMC6162646 | biostudies-literature